Anjum S. Kaka, R. MacDonald, N. Greer
Feb 9, 2021
Citations
0
Influential Citations
34
Citations
Journal
Annals of Internal Medicine
Abstract
Remdesivir is being studied for the treatment of COVID-19. This first update of a living rapid review used to inform American College of Physicians Practice Points includes information from a newly published large multinational randomized controlled trial (RCT) as well as the final results of an RCT previously published as a preliminary report. This update presents the results of new meta-analyses on the effect of remdesivir on mortality and nonmortality outcomes and determines aggregate certainty of evidence on the effectiveness of 5 versus 10 days of remdesivir therapy on the basis of previously published data.